The Asia Pacific Medical Thawing System Market would witness market growth of 12% CAGR during the forecast period (2020-2026).
The region comprises of growing economies, significantly China, India, and Japan. These nations consist of a huge number of patients with a high chronic disease rate. A rise in the number of chronic diseases that result in failures of organs is anticipated to fuel the demand for thawed blood. These nations are creating devices that are innovative and advanced and offer different ultra-modern surgical procedure choices with thriving medical tourism. Comparatively, the lower cost of treatment in the region is the factor that attracts a huge number of patients to visit for medical reasons. These components are anticipated to boost the growth in the Asia Pacific region.
The medical thawing systems market is fueled by the existence of big biopharmaceutical organizations that deploy these frameworks in their production units. With the increasing regional increment of biopharmaceutical businesses owing to the rising product manufacturing in the region, led to the growth of medical thawing systems. In these industries, medical thawing systems are transferred with containers for the cycle of development and aseptic transfers from lab to industrial scales. Thawing systems are equipped with three main elements: a cooling and heating unit, a container, and a thawing instrument. The container is mostly utilized for rapid fast freezing, thawing, and transporting biopharmaceutical items. The thawing instrument is utilized for the smooth execution of the batch process.
Based on Product Type, the market is segmented into Manual and Automated. Based on Sample Type, the market is segmented into Blood, Ovum, Semen, Embryo and Others. Based on End Use, the market is segmented into Blood Bank & Transfusion centers, Hospitals, Tissue Banks, Biotechnology & Pharma and Other End Uses. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Thermo Fisher Scientific, Inc., Cardinal Health, Inc., Helmer Scientific, Inc., Sarstedt AG & Company, Boekel Scientific, Inc., Barkey GmbH & Co. KG, BioCision LLC, Sartorius AG and CytoTherm LP.
Scope of the Study
Market Segments Covered in the Report:
By Product Type
By Sample Type
By End Use
• Blood Bank & Transfusion centers
• Tissue Banks
• Biotechnology & Pharma
• Other End Uses
• South Korea
• Rest of Asia Pacific
• General Electric (GE) Co. (GE Healthcare)
• Thermo Fisher Scientific, Inc.
• Cardinal Health, Inc.
• Helmer Scientific, Inc.
• Sarstedt AG & Company
• Boekel Scientific, Inc.
• Barkey GmbH & Co. KG
• BioCision LLC
• Sartorius AG
• CytoTherm LP
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
Real-world data and real-world evidence are used to monitor the post-market safety and adverse events of drugs.The monitoring of this data assists in making regulatory decisions. The healthcare community is using RWE and RWD to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice. The...
The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8% from 2021 to 2026. Growth in this market is driven by the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization, and the growing prevalence of diseases Microplate...
The nanofiber market in Asia Pacific is expected to reach US$ 1,424.49 million by 2028 from US$ 253.27 million in 2021. The market is estimated to grow at a CAGR of 28.0% from 2021 to 2028. The electrospinning of fibers has been widely adopted as the simplest, yet effective and the productive approach for the production of nanofibers.Electrostatic...
The global NLP in healthcare and life sciences market size to grow from USD 1.8 billion in 2021 to USD 4.3 billion by 2026, at a Compound Annual Growth Rate (CAGR) of 19.0% during the forecast period. Various factors such as the growing need to analyze and extract insights from narrative text and huge amount of clinical data, and rising demand...
128 pages •
By Asia Market Information & Development Company
• Aug 2021
This study focuses on China’s Caps and Closures industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of...
The ePRO, ePatient diaries, and eCOA market in Asia Pacific is expected to grow from US$ 348.8 million in 2021 to US$ 964.2 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. Healthcare systems are experiencing a rise in consumer engagement worldwide. In developing countries, health care systems are becoming more...
histopathology services market was valued at US$ 35,187.90 million by 2028 from US$ 23,890.44 million in 2021; it is expected to grow at a CAGR of 5.7% from 2021 to 2028. Factors such as rising demand for biologics and increasing prevalence of chronic diseases are driving the growth of the histopathology services market. However, limitations...
Gene therapy: More than half of industry revenue is generated by sales of healthcare products Abstract Biotechnology in the US The Biotechnology industry is growing quickly, characterized by a multitude of product applications and a wide range of burgeoning markets. Growing demand for ethanol indicates...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.